Henrik Dohlman, PhD, discovered why seemingly identical cells might react differently to the chemical signals inside our bodies and the drugs we use to battle diseases.
Though cancer screening has come a long way, physicians still do not thoroughly discuss with patients the advantages and disadvantages of these procedures before decisions are made to undergo the screenings, according to a new study co-authored by a UNC physician.
The discovery, from the lab of Brian Strahl, PhD, offers insights for the creation of better, more targeted therapies for various forms of cancer.
Why are some 75-year-olds downright spry while others can barely get around? New research provides part of the explanation.
By waiting to trigger the drug's potency, the method may provide a better route toward treating malignant tumors.
The new collaborative effort capitalizes on the scientific and clinical strengths of the comprehensive cancer centers at each of the three institutions, working within the National Cancer Institute’s Experimental Therapeutics Clinical Trials Network (ETCTN).
Five Questions for Robert Sandler, a world-renowned gastroenterologist who has challenged a major theory about the cause of diverticulosis.
Previously thought to only play a role in male fertility, the protein DAZAP1 has now been shown to be a major player in how genes are expressed; in cell culture experiments it stifled the progression of several types of cancer cells.
The John William Pope Foundation has made a $1.3 million gift to UNC Lineberger Comprehensive Cancer Center to fund cancer research and treatment.
The findings shed more light on cancer development and metastasis.
Five questions for Chuck Perou, PhD, a UNC geneticist on the hunt for better treatments for the most deadly form of breast cancer
With the dedication of Marsico Hall, UNC ushered in a new era of medical research, collaboration, and promise for the people of North Carolina and beyond.
Using a test developed at UNC Lineberger Comprehensive Cancer Center to determine molecular aging, UNC oncologists have directly measured the impact of anti-cancer chemotherapy drugs on biological aging.
The finding, from the lab of William Marzluff, PhD, provides insight into how genetic diseases, such as various cancers, develop in the body.
The large-scale, cross-sectional study was published in The New England Journal of Medicine. Dr. David Ransohoff of UNC is one of the study's co-authors.
The lab of Klaus Hahn, PhD, developed a new technique to help scientists map the interactions between the proteins at the heart of many diseases.
When we fight an infection -- any invader -- our bodies conjure inflammatory responses, immune responses. But inside some individual cells, a similar reaction happens. Beth Knight, PhD, found out what transpires inside such cells involved in a kind of brain cancer called medulloblastoma and what role a particularly important protein plays in cancer development. This is the second profile in a continuing series of features on UNC School of Medicine graduate students.
Researchers at the UNC Lineberger Comprehensive Cancer Center found that bladder cancer subtypes are genetically similar to breast cancer subtypes.
The new technique, developed by UNC researchers, would be cheaper and could allow doctors to visualize tumors without the use of radiation.
This research could reduce the need to continually monitor patients who respond well to stereotactic radiosurgery.